Consultation News and Research

RSS

Direct-to-Consumer Blood Test for Assessing User’s Alzheimer’s Disease Risk

In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market. The test, which has not undergone Food and Drug Administration (FDA) review, measures the level of a protein called beta amyloid, a key component of plaques that form in the brains of Alzheimer’s disease patients, disrupting brain function.

23 Aug 2023

Analyzing the First Vaccine Against Respiratory Syncytial Virus in Many Older Adults

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

23 Aug 2023

Kimberly-Clark Goes Green in North Wales with Renewable Energy for Tissue Manufacturing

HYRO - a joint venture between RES and Octopus Energy Generation – has submitted a planning application to Flintshire County Council for its Coleshill Green Hydrogen Project.

27 Jul 2023

Researchers identify genes related with plant survival in the Atacama Desert in Chile

An international team of researchers has identified genes associated with plant survival in one of the harshest environments on Earth: the Atacama Desert in Chile.

From New York University (NYU) 2 Nov 2021

Does the Future of Farming Involve the Gene Editing of Farm Animals?

In this interview, AZoLifeSciences speaks to the RSPCA about the future of farming, and whether it involves gene-edited farm animals.

8 Oct 2021

Scientists emphasize the need for commercialization in gene editing research

The UK Government published plans to replace the prevailing European Union regulations in using gene editing in UK agricultural practices.

1 Oct 2021

Restek’s New Terpenes MegaMix Standards: 59 Compounds in Two Ampuls to Optimize Your Terpenes Analyses

Terpenes are aromatic compounds responsible for the characteristic aromas and flavors of most plants.

From Restek Corporation 1 Oct 2021

Groundbreaking field trials underscore the potential of gene-editing technology

Field trials that explore healthy chemicals in agronomically significant brassica crops have underscored the “immense potential” of gene-editing technology.

22 Jun 2021

New transformative pathways to build a more resilient and sustainable future

It is clear that COVID-19 has drastically changed our world, but how can we use the lessons learnt to build a more resilient and sustainable future? The International Institute for Applied Systems Analysis (IIASA) and the International Science Council (ISC) have drawn on the combined strengths and expertise of the two organizations to help find a way forward.

27 Jan 2021

New study explores the role of genetics in prostate cancer

When compared to other groups, certain ethnic and racial groups tend to suffer more often, and fare worse, from common ailments.

5 Jan 2021

Researchers are testing new way to deliver vaccines through microneedle skin patches

A revolutionary new way to give vaccines through microneedle skin patches is being tested at Swansea University, thanks to £200,000 of EU funding announced by the Welsh Government.

10 Aug 2020

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics spin-off, the aim of which is to develop new immuno-oncological therapeutic tools with various preclinical candidates, based on CAR-T technology for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), a rare subtype of leukemia that mainly affects children, and which has a poor prognosis.

21 Jul 2020